$Kodiak Sciences (KOD.US)$
Breakthrough Eye Disease Platform: Kodiak Sciences Reveals 7 Major Advances at ARVO 2025

$Kodiak Sciences (KOD.US)$
Breakthrough Eye Disease Platform: Kodiak Sciences Reveals 7 Major Advances at ARVO 2025

$Kodiak Sciences (KOD.US)$ Kodiak completes acquisition of Sunocs LLC, operating the largest grease and silicone manufacturing facility in North America
PR Newswire
CINCINNATI, April 29, 2025 /PRNewswire/ -- Kodiak LLC., a leading provider of specialty chemicals, announced its acquisition of Sunocs LLC this spring. The strategic purchase of Sunocs' new grease and silicone manufacturing facility and customer base represents Kodiak's fifth acquisition since 2023. Sunocs' assets amplify Kodiak...

$Kodiak Sciences (KOD.US)$
Kodiak Sciences Cuts Losses by 26%, Advances Two Phase 3 Trials with $168M War Chest

$Kodiak Sciences (KOD.US)$
Clinical Trial Success: Kodiak Enrolls 250+ Patients for Novel Diabetic Eye Drug

$Kodiak Sciences (KOD.US)$ riding 9 nicely 👌 looking for possible swing entry on pullback

» Holdings: 87
» Holdings in Top 20: 86.71%
» Qtr over Qtr Change**: -9.29%
Top Holdings:
$Incyte (INCY.US)$
$BeiGene (BGNE.US)$
$ACADIA Pharmaceuticals (ACAD.US)$
$Madrigal Pharmaceuticals (MDGL.US)$
$Rhythm Pharmaceuticals (RYTM.US)$
$Revolution Medicines (RVMD.US)$
$Kymera Therapeutics (KYMR.US)$
$AbCellera Biologics (ABCL.US)$
$Bicycle Therapeutics (BCYC.US)$
$Edgewise Therapeutics (EWTX.US)$
$Immunocore (IMCR.US)$
$Kodiak Sciences (KOD.US)$
$Roivant Sciences (ROIV.US)$
...

$Kodiak Sciences (KOD.US)$
NEWS
Kodiak Sciences Announces Treatment of First Patients in Phase 3 GLOW2 Study of Tarcocimab Tedromer in Diabetic Retinopathy

$Kodiak Sciences (KOD.US)$
NEWS
Kodiak Sciences Data at ARVO 2024 Highlight Depth of Early and Late-Phase Retina Pipeline including Advancements with High Drug-Antibody-Ratio Therapeutics Built on Kodiak's Antibody Biopolymer Conjugate (ABC) Platform